nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—S100A12—nose—brain cancer	0.0946	0.242	CbGeAlD
Amlexanox—PDE4C—ganglion—brain cancer	0.0203	0.0519	CbGeAlD
Amlexanox—Throat sore—Lomustine—brain cancer	0.0172	0.143	CcSEcCtD
Amlexanox—Oropharyngeal discomfort—Lomustine—brain cancer	0.017	0.142	CcSEcCtD
Amlexanox—FGF1—ganglion—brain cancer	0.0167	0.0428	CbGeAlD
Amlexanox—FGF1—endothelium—brain cancer	0.0144	0.0369	CbGeAlD
Amlexanox—IL3—endocrine gland—brain cancer	0.0139	0.0356	CbGeAlD
Amlexanox—Oropharyngeal pain—Lomustine—brain cancer	0.0136	0.113	CcSEcCtD
Amlexanox—FGF1—blood vessel—brain cancer	0.0133	0.034	CbGeAlD
Amlexanox—FGF1—hindbrain—brain cancer	0.0127	0.0324	CbGeAlD
Amlexanox—PDE4C—brainstem—brain cancer	0.00882	0.0226	CbGeAlD
Amlexanox—S100A13—gonad—brain cancer	0.00874	0.0224	CbGeAlD
Amlexanox—S100A12—pituitary gland—brain cancer	0.00841	0.0215	CbGeAlD
Amlexanox—PDE4C—telencephalon—brain cancer	0.00783	0.02	CbGeAlD
Amlexanox—FGF1—brainstem—brain cancer	0.00726	0.0186	CbGeAlD
Amlexanox—PDE4D—telencephalon—brain cancer	0.00689	0.0176	CbGeAlD
Amlexanox—Stomatitis—Lomustine—brain cancer	0.00676	0.0562	CcSEcCtD
Amlexanox—S100A13—endocrine gland—brain cancer	0.0066	0.0169	CbGeAlD
Amlexanox—S100A13—head—brain cancer	0.00652	0.0167	CbGeAlD
Amlexanox—S100A12—endocrine gland—brain cancer	0.00652	0.0167	CbGeAlD
Amlexanox—FGF1—telencephalon—brain cancer	0.00645	0.0165	CbGeAlD
Amlexanox—S100A12—head—brain cancer	0.00643	0.0165	CbGeAlD
Amlexanox—PDE4A—telencephalon—brain cancer	0.0061	0.0156	CbGeAlD
Amlexanox—S100A13—central nervous system—brain cancer	0.00595	0.0152	CbGeAlD
Amlexanox—S100A13—cerebellum—brain cancer	0.00582	0.0149	CbGeAlD
Amlexanox—PDE4C—midbrain—brain cancer	0.00562	0.0144	CbGeAlD
Amlexanox—FGF1—pituitary gland—brain cancer	0.00525	0.0134	CbGeAlD
Amlexanox—FGF1—medulla oblongata—brain cancer	0.00506	0.013	CbGeAlD
Amlexanox—PDE4C—head—brain cancer	0.00487	0.0125	CbGeAlD
Amlexanox—S100A13—brain—brain cancer	0.00472	0.0121	CbGeAlD
Amlexanox—S100A12—brain—brain cancer	0.00466	0.0119	CbGeAlD
Amlexanox—FGF1—midbrain—brain cancer	0.00463	0.0118	CbGeAlD
Amlexanox—FGF1—spinal cord—brain cancer	0.00452	0.0116	CbGeAlD
Amlexanox—PDE4C—central nervous system—brain cancer	0.00445	0.0114	CbGeAlD
Amlexanox—Pain—Carboplatin—brain cancer	0.00432	0.0359	CcSEcCtD
Amlexanox—Stomatitis—Procarbazine—brain cancer	0.00429	0.0357	CcSEcCtD
Amlexanox—FGF1—endocrine gland—brain cancer	0.00407	0.0104	CbGeAlD
Amlexanox—FGF1—head—brain cancer	0.00401	0.0103	CbGeAlD
Amlexanox—PDE4D—cerebellum—brain cancer	0.00383	0.0098	CbGeAlD
Amlexanox—FGF1—central nervous system—brain cancer	0.00366	0.00938	CbGeAlD
Amlexanox—PDE4B—telencephalon—brain cancer	0.00364	0.0093	CbGeAlD
Amlexanox—FGF1—cerebellum—brain cancer	0.00358	0.00916	CbGeAlD
Amlexanox—PDE4C—brain—brain cancer	0.00353	0.00904	CbGeAlD
Amlexanox—Mouth ulceration—Etoposide—brain cancer	0.00344	0.0286	CcSEcCtD
Amlexanox—PDE4A—cerebellum—brain cancer	0.00339	0.00867	CbGeAlD
Amlexanox—Stomatitis—Hydroxyurea—brain cancer	0.00332	0.0276	CcSEcCtD
Amlexanox—Liver function test abnormal—Carmustine—brain cancer	0.0033	0.0274	CcSEcCtD
Amlexanox—PDE4D—brain—brain cancer	0.00311	0.00796	CbGeAlD
Amlexanox—PDE4B—gonad—brain cancer	0.00303	0.00777	CbGeAlD
Amlexanox—PDE4B—pituitary gland—brain cancer	0.00296	0.00758	CbGeAlD
Amlexanox—FGF1—brain—brain cancer	0.00291	0.00744	CbGeAlD
Amlexanox—PDE4B—medulla oblongata—brain cancer	0.00286	0.00731	CbGeAlD
Amlexanox—PDE4A—brain—brain cancer	0.00275	0.00704	CbGeAlD
Amlexanox—Stomatitis—Carmustine—brain cancer	0.00268	0.0223	CcSEcCtD
Amlexanox—Nausea—Lomustine—brain cancer	0.00263	0.0218	CcSEcCtD
Amlexanox—PDE4B—midbrain—brain cancer	0.00261	0.00668	CbGeAlD
Amlexanox—Stomatitis—Temozolomide—brain cancer	0.00259	0.0216	CcSEcCtD
Amlexanox—PDE4B—spinal cord—brain cancer	0.00255	0.00652	CbGeAlD
Amlexanox—Paraesthesia—Procarbazine—brain cancer	0.00252	0.021	CcSEcCtD
Amlexanox—Pain—Procarbazine—brain cancer	0.0024	0.02	CcSEcCtD
Amlexanox—PDE4B—endocrine gland—brain cancer	0.00229	0.00587	CbGeAlD
Amlexanox—PDE4B—head—brain cancer	0.00226	0.00579	CbGeAlD
Amlexanox—Nervous system disorder—Hydroxyurea—brain cancer	0.00213	0.0177	CcSEcCtD
Amlexanox—Stomatitis—Etoposide—brain cancer	0.00208	0.0173	CcSEcCtD
Amlexanox—PDE4B—central nervous system—brain cancer	0.00207	0.00529	CbGeAlD
Amlexanox—PDE4B—cerebellum—brain cancer	0.00202	0.00517	CbGeAlD
Amlexanox—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00188	0.0156	CcSEcCtD
Amlexanox—Pain—Hydroxyurea—brain cancer	0.00186	0.0154	CcSEcCtD
Amlexanox—Headache—Procarbazine—brain cancer	0.00176	0.0146	CcSEcCtD
Amlexanox—Nausea—Procarbazine—brain cancer	0.00167	0.0139	CcSEcCtD
Amlexanox—Nervous system disorder—Temozolomide—brain cancer	0.00166	0.0138	CcSEcCtD
Amlexanox—PDE4B—brain—brain cancer	0.00164	0.0042	CbGeAlD
Amlexanox—Paraesthesia—Carmustine—brain cancer	0.00158	0.0131	CcSEcCtD
Amlexanox—Paraesthesia—Temozolomide—brain cancer	0.00152	0.0127	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Carmustine—brain cancer	0.00152	0.0126	CcSEcCtD
Amlexanox—Pain—Carmustine—brain cancer	0.0015	0.0125	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Temozolomide—brain cancer	0.00146	0.0122	CcSEcCtD
Amlexanox—Pain—Temozolomide—brain cancer	0.00145	0.0121	CcSEcCtD
Amlexanox—Headache—Hydroxyurea—brain cancer	0.00136	0.0113	CcSEcCtD
Amlexanox—Nausea—Hydroxyurea—brain cancer	0.00129	0.0107	CcSEcCtD
Amlexanox—Paraesthesia—Etoposide—brain cancer	0.00122	0.0101	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Etoposide—brain cancer	0.00117	0.00975	CcSEcCtD
Amlexanox—Pain—Etoposide—brain cancer	0.00116	0.00966	CcSEcCtD
Amlexanox—Headache—Carmustine—brain cancer	0.0011	0.00915	CcSEcCtD
Amlexanox—Headache—Temozolomide—brain cancer	0.00106	0.00884	CcSEcCtD
Amlexanox—Nausea—Carmustine—brain cancer	0.00104	0.00867	CcSEcCtD
Amlexanox—Nausea—Temozolomide—brain cancer	0.00101	0.00838	CcSEcCtD
Amlexanox—Headache—Etoposide—brain cancer	0.000851	0.00707	CcSEcCtD
Amlexanox—Nausea—Etoposide—brain cancer	0.000807	0.00671	CcSEcCtD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—EGFR—brain cancer	0.000298	0.00061	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—GLI1—brain cancer	0.000298	0.000609	CbGpPWpGaD
Amlexanox—FGF1—Disease—DLL1—brain cancer	0.000297	0.000607	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—HEY1—brain cancer	0.000297	0.000607	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—EGFR—brain cancer	0.000296	0.000605	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—RELA—brain cancer	0.000295	0.000604	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—RELA—brain cancer	0.000295	0.000602	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—ERBB2—brain cancer	0.000293	0.0006	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—EGFR—brain cancer	0.000293	0.000599	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—ERBB2—brain cancer	0.000293	0.000599	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NOTCH2—brain cancer	0.000293	0.000598	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—EGFR—brain cancer	0.000292	0.000597	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—DLL1—brain cancer	0.000291	0.000595	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—STAT3—brain cancer	0.000291	0.000595	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—VAV1—brain cancer	0.00029	0.000593	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ABR—brain cancer	0.000289	0.000591	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000287	0.000587	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—GLI1—brain cancer	0.000283	0.00058	CbGpPWpGaD
Amlexanox—S100A12—Immune System—PDGFRA—brain cancer	0.000283	0.000579	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SUFU—brain cancer	0.000282	0.000577	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000281	0.000574	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—GLI2—brain cancer	0.000279	0.000571	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—VAV1—brain cancer	0.000279	0.00057	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—PDGFRA—brain cancer	0.000278	0.000568	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—EGFR—brain cancer	0.000276	0.000565	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—VAV1—brain cancer	0.000276	0.000565	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—GFAP—brain cancer	0.000272	0.000557	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ABR—brain cancer	0.000269	0.000551	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SUFU—brain cancer	0.000269	0.00055	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—PDGFRA—brain cancer	0.000267	0.000546	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—EGFR—brain cancer	0.000264	0.00054	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—VAV1—brain cancer	0.000263	0.000539	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—GLI1—brain cancer	0.000262	0.000536	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—GLI2—brain cancer	0.00026	0.000532	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—GFAP—brain cancer	0.000259	0.00053	CbGpPWpGaD
Amlexanox—FGF1—Immune System—SKP2—brain cancer	0.000259	0.00053	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—HEY1—brain cancer	0.000258	0.000528	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CTNNB1—brain cancer	0.000256	0.000524	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—VAV1—brain cancer	0.000255	0.000522	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—DLL1—brain cancer	0.000253	0.000518	CbGpPWpGaD
Amlexanox—FGF1—Disease—ENO2—brain cancer	0.000253	0.000516	CbGpPWpGaD
Amlexanox—FGF1—Disease—SHH—brain cancer	0.000253	0.000516	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—VAV1—brain cancer	0.000251	0.000513	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SUFU—brain cancer	0.000249	0.000509	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IRS2—brain cancer	0.000249	0.000508	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SHH—brain cancer	0.000247	0.000506	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—HEY1—brain cancer	0.000246	0.000503	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—GLI1—brain cancer	0.000245	0.0005	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—IRS2—brain cancer	0.000244	0.000499	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—DLL1—brain cancer	0.000241	0.000493	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—GFAP—brain cancer	0.00024	0.000491	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—HES1—brain cancer	0.00024	0.000491	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TRPC6—brain cancer	0.000239	0.000488	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—TP53—brain cancer	0.000236	0.000483	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.000236	0.000482	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PTCH1—brain cancer	0.000234	0.00048	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SMO—brain cancer	0.000234	0.00048	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—IRS2—brain cancer	0.000234	0.000479	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—IL2—brain cancer	0.000232	0.000475	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—VAV1—brain cancer	0.000232	0.000474	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SUFU—brain cancer	0.000232	0.000474	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—PDGFRA—brain cancer	0.000228	0.000467	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—HEY1—brain cancer	0.000227	0.000465	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—GFAP—brain cancer	0.000224	0.000458	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—STAT3—brain cancer	0.000224	0.000457	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—DLL1—brain cancer	0.000223	0.000456	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—SPP1—brain cancer	0.000222	0.000453	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SHH—brain cancer	0.000215	0.00044	CbGpPWpGaD
Amlexanox—IL3—Immune System—RELA—brain cancer	0.000214	0.000438	CbGpPWpGaD
Amlexanox—IL3—Immune System—ERBB2—brain cancer	0.000213	0.000435	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—HEY1—brain cancer	0.000212	0.000434	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—PIK3CG—brain cancer	0.000212	0.000433	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—IL2—brain cancer	0.000211	0.000431	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—DLL1—brain cancer	0.000208	0.000425	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TRPC6—brain cancer	0.000208	0.000425	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SHH—brain cancer	0.000205	0.000419	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PTCH1—brain cancer	0.000204	0.000417	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SMO—brain cancer	0.000204	0.000417	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—EGFR—brain cancer	0.000203	0.000416	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—EGFR—brain cancer	0.000203	0.000415	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IRS2—brain cancer	0.000201	0.00041	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TRPC6—brain cancer	0.000198	0.000404	CbGpPWpGaD
Amlexanox—FGF1—Immune System—VAV1—brain cancer	0.000198	0.000404	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PTCH1—brain cancer	0.000194	0.000397	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SMO—brain cancer	0.000194	0.000397	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL2—brain cancer	0.000193	0.000394	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—PIK3CG—brain cancer	0.000192	0.000393	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SHH—brain cancer	0.00019	0.000388	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NOTCH2—brain cancer	0.000187	0.000383	CbGpPWpGaD
Amlexanox—IL3—Immune System—CTNNB1—brain cancer	0.000186	0.000381	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—PIK3CG—brain cancer	0.000184	0.000377	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TRPC6—brain cancer	0.000183	0.000374	CbGpPWpGaD
Amlexanox—FGF1—Disease—VAV1—brain cancer	0.000182	0.000373	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SMO—brain cancer	0.00018	0.000368	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PTCH1—brain cancer	0.00018	0.000368	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—VAV1—brain cancer	0.000179	0.000365	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—APC—brain cancer	0.000177	0.000362	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—PIK3CG—brain cancer	0.000177	0.000362	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SHH—brain cancer	0.000177	0.000362	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—PIK3CG—brain cancer	0.000175	0.000358	CbGpPWpGaD
Amlexanox—S100A12—Immune System—RELA—brain cancer	0.000172	0.000351	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TRPC6—brain cancer	0.000171	0.000349	CbGpPWpGaD
Amlexanox—S100A12—Immune System—ERBB2—brain cancer	0.00017	0.000349	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—RELA—brain cancer	0.000168	0.000344	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SMO—brain cancer	0.000168	0.000343	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PTCH1—brain cancer	0.000168	0.000343	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—ERBB2—brain cancer	0.000167	0.000342	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—PIK3CG—brain cancer	0.000167	0.000342	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NOTCH2—brain cancer	0.000163	0.000334	CbGpPWpGaD
Amlexanox—IL3—Immune System—STAT3—brain cancer	0.000162	0.000332	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—PIK3CG—brain cancer	0.000162	0.000332	CbGpPWpGaD
Amlexanox—FGF1—Immune System—PDGFRA—brain cancer	0.000162	0.000331	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—RELA—brain cancer	0.000162	0.000331	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—EGFR—brain cancer	0.000161	0.00033	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—ERBB2—brain cancer	0.000161	0.000328	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—PIK3CG—brain cancer	0.000159	0.000326	CbGpPWpGaD
Amlexanox—FGF1—Disease—HES1—brain cancer	0.000157	0.000321	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—VAV1—brain cancer	0.000156	0.000318	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NOTCH2—brain cancer	0.000155	0.000318	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL2—brain cancer	0.000154	0.000316	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—HES1—brain cancer	0.000154	0.000314	CbGpPWpGaD
Amlexanox—FGF1—Disease—PDGFRA—brain cancer	0.000149	0.000306	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CTNNB1—brain cancer	0.000149	0.000305	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—IL2—brain cancer	0.000149	0.000304	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—VAV1—brain cancer	0.000148	0.000303	CbGpPWpGaD
Amlexanox—IL3—Immune System—EGFR—brain cancer	0.000147	0.000302	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—PIK3CG—brain cancer	0.000147	0.000301	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PDGFRA—brain cancer	0.000146	0.000299	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CTNNB1—brain cancer	0.000146	0.000299	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NOTCH2—brain cancer	0.000144	0.000294	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SPP1—brain cancer	0.000142	0.000291	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IRS2—brain cancer	0.000142	0.000291	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—RELA—brain cancer	0.000138	0.000283	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—ERBB2—brain cancer	0.000138	0.000281	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—VAV1—brain cancer	0.000137	0.00028	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL2—brain cancer	0.000135	0.000276	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NOTCH2—brain cancer	0.000134	0.000274	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—HES1—brain cancer	0.000134	0.000274	CbGpPWpGaD
Amlexanox—FGF1—Disease—IRS2—brain cancer	0.000131	0.000268	CbGpPWpGaD
Amlexanox—S100A12—Immune System—STAT3—brain cancer	0.00013	0.000266	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—IL2—brain cancer	0.00013	0.000265	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IRS2—brain cancer	0.000128	0.000263	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—VAV1—brain cancer	0.000128	0.000261	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PDGFRA—brain cancer	0.000127	0.000261	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—HES1—brain cancer	0.000127	0.00026	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL2—brain cancer	0.000125	0.000255	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SPP1—brain cancer	0.000124	0.000253	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—IL2—brain cancer	0.000123	0.000252	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CCND1—brain cancer	0.000121	0.000248	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PDGFRA—brain cancer	0.000121	0.000248	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CTNNB1—brain cancer	0.00012	0.000246	CbGpPWpGaD
Amlexanox—S100A12—Immune System—EGFR—brain cancer	0.000118	0.000242	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—HES1—brain cancer	0.000118	0.000241	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SPP1—brain cancer	0.000118	0.000241	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL2—brain cancer	0.000118	0.000241	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—EGFR—brain cancer	0.000116	0.000237	CbGpPWpGaD
Amlexanox—FGF1—Disease—APC—brain cancer	0.000116	0.000237	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—IL2—brain cancer	0.000114	0.000233	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—APC—brain cancer	0.000113	0.000232	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PIK3CG—brain cancer	0.000113	0.000232	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PDGFRA—brain cancer	0.000112	0.000229	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL2—brain cancer	0.000112	0.000229	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IRS2—brain cancer	0.000112	0.000229	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—EGFR—brain cancer	0.000111	0.000228	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—HES1—brain cancer	0.00011	0.000225	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SPP1—brain cancer	0.000109	0.000223	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IRS2—brain cancer	0.000106	0.000218	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—VEGFA—brain cancer	0.000106	0.000217	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—STAT3—brain cancer	0.000105	0.000214	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PDGFRA—brain cancer	0.000105	0.000214	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL2—brain cancer	0.000104	0.000212	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—EGFR—brain cancer	0.000103	0.000211	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SPP1—brain cancer	0.000102	0.000208	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—APC—brain cancer	9.88e-05	0.000202	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PIK3CG—brain cancer	9.88e-05	0.000202	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IRS2—brain cancer	9.85e-05	0.000201	CbGpPWpGaD
Amlexanox—FGF1—Immune System—RELA—brain cancer	9.8e-05	0.0002	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MYC—brain cancer	9.74e-05	0.000199	CbGpPWpGaD
Amlexanox—FGF1—Immune System—ERBB2—brain cancer	9.74e-05	0.000199	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—EGFR—brain cancer	9.53e-05	0.000195	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—APC—brain cancer	9.4e-05	0.000192	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PIK3CG—brain cancer	9.4e-05	0.000192	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IRS2—brain cancer	9.18e-05	0.000188	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—EGFR—brain cancer	9e-05	0.000184	CbGpPWpGaD
Amlexanox—FGF1—Disease—ERBB2—brain cancer	8.99e-05	0.000184	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—RELA—brain cancer	8.87e-05	0.000181	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL2—brain cancer	8.83e-05	0.000181	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ERBB2—brain cancer	8.81e-05	0.00018	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—APC—brain cancer	8.7e-05	0.000178	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PIK3CG—brain cancer	8.7e-05	0.000178	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—EGFR—brain cancer	8.57e-05	0.000175	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CTNNB1—brain cancer	8.52e-05	0.000174	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—APC—brain cancer	8.11e-05	0.000166	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PIK3CG—brain cancer	8.11e-05	0.000166	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TP53—brain cancer	8e-05	0.000164	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL2—brain cancer	7.98e-05	0.000163	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—EGFR—brain cancer	7.93e-05	0.000162	CbGpPWpGaD
Amlexanox—FGF1—Disease—CTNNB1—brain cancer	7.87e-05	0.000161	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCND1—brain cancer	7.78e-05	0.000159	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—RELA—brain cancer	7.72e-05	0.000158	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CTNNB1—brain cancer	7.71e-05	0.000158	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ERBB2—brain cancer	7.67e-05	0.000157	CbGpPWpGaD
Amlexanox—FGF1—Immune System—STAT3—brain cancer	7.43e-05	0.000152	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RELA—brain cancer	7.35e-05	0.00015	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ERBB2—brain cancer	7.3e-05	0.000149	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL2—brain cancer	6.95e-05	0.000142	CbGpPWpGaD
Amlexanox—FGF1—Disease—STAT3—brain cancer	6.86e-05	0.00014	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RELA—brain cancer	6.8e-05	0.000139	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—VEGFA—brain cancer	6.79e-05	0.000139	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCND1—brain cancer	6.78e-05	0.000139	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ERBB2—brain cancer	6.75e-05	0.000138	CbGpPWpGaD
Amlexanox—FGF1—Immune System—EGFR—brain cancer	6.75e-05	0.000138	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—STAT3—brain cancer	6.72e-05	0.000137	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CTNNB1—brain cancer	6.71e-05	0.000137	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL2—brain cancer	6.62e-05	0.000135	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCND1—brain cancer	6.45e-05	0.000132	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CTNNB1—brain cancer	6.39e-05	0.000131	CbGpPWpGaD
Amlexanox—FGF1—Disease—MYC—brain cancer	6.37e-05	0.00013	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RELA—brain cancer	6.34e-05	0.00013	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ERBB2—brain cancer	6.3e-05	0.000129	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MYC—brain cancer	6.24e-05	0.000128	CbGpPWpGaD
Amlexanox—FGF1—Disease—EGFR—brain cancer	6.23e-05	0.000128	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL2—brain cancer	6.12e-05	0.000125	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—EGFR—brain cancer	6.11e-05	0.000125	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCND1—brain cancer	5.97e-05	0.000122	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CTNNB1—brain cancer	5.91e-05	0.000121	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—VEGFA—brain cancer	5.91e-05	0.000121	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—STAT3—brain cancer	5.85e-05	0.00012	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL2—brain cancer	5.71e-05	0.000117	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—VEGFA—brain cancer	5.62e-05	0.000115	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—STAT3—brain cancer	5.57e-05	0.000114	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCND1—brain cancer	5.56e-05	0.000114	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CTNNB1—brain cancer	5.51e-05	0.000113	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MYC—brain cancer	5.44e-05	0.000111	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—EGFR—brain cancer	5.32e-05	0.000109	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—VEGFA—brain cancer	5.2e-05	0.000106	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MYC—brain cancer	5.17e-05	0.000106	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—STAT3—brain cancer	5.15e-05	0.000105	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TP53—brain cancer	5.13e-05	0.000105	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—EGFR—brain cancer	5.06e-05	0.000103	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—VEGFA—brain cancer	4.85e-05	9.92e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—STAT3—brain cancer	4.8e-05	9.82e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MYC—brain cancer	4.79e-05	9.79e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—EGFR—brain cancer	4.68e-05	9.58e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TP53—brain cancer	4.46e-05	9.13e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MYC—brain cancer	4.46e-05	9.13e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—EGFR—brain cancer	4.37e-05	8.93e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TP53—brain cancer	4.25e-05	8.69e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TP53—brain cancer	3.93e-05	8.04e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TP53—brain cancer	3.67e-05	7.5e-05	CbGpPWpGaD
